HBAN vs MGRX · P/E 13, rev $1.56B vs rev $456.0K
Huntington Bancshares Incorporated (HBAN) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the HBAN and MGRX stock pages for the full models.
Not investment advice.